title: Why do we need a newer generation of recombinant vaccines against hepatitis B?
authors.affiliation: Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA.
authors.forename: N
authors.initials: N
authors.lastname: Chalasani
authors.forename: N
authors.initials: N
authors.lastname: Gitlin
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000293:Adolescent; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D006509:Hepatitis B / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007117:Immunization, Secondary; D008875:Middle Aged; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000008:administration & dosage
chemical_list: D000276:Adjuvants, Immunologic; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic